NCT01677572 · Interventional trial
Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease
Overall registry status Terminated
Phase 1
Conditions Alzheimer's Disease
Delaware Valley sites
- CRI Lifetree · Marlton, NJ · Burlington County
First posted
Registry updated
Added to the directory